As of 2025-12-21, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 157.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 456.20 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -65.5%.
The range of the Relative Valuation is 22.86 - 373.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 25.8x | 20.1x |
| Forward P/E multiples | 19.8x - 22.5x | 20.8x |
| Fair Price | 22.86 - 373.71 | 157.58 |
| Upside | -95.0% - -18.1% | -65.5% |
| Date | P/E |
| 2025-12-19 | 31.49 |
| 2025-12-18 | 30.89 |
| 2025-12-17 | 31.03 |
| 2025-12-16 | 31.41 |
| 2025-12-15 | 31.46 |
| 2025-12-12 | 31.21 |
| 2025-12-11 | 30.79 |
| 2025-12-10 | 30.70 |
| 2025-12-09 | 30.17 |
| 2025-12-08 | 30.52 |
| 2025-12-05 | 31.45 |
| 2025-12-04 | 31.58 |
| 2025-12-03 | 31.97 |
| 2025-12-02 | 29.90 |
| 2025-12-01 | 29.38 |
| 2025-11-28 | 29.94 |
| 2025-11-26 | 29.84 |
| 2025-11-25 | 29.67 |
| 2025-11-24 | 29.27 |
| 2025-11-21 | 29.46 |
| 2025-11-20 | 29.16 |
| 2025-11-19 | 29.07 |
| 2025-11-18 | 30.07 |
| 2025-11-17 | 29.96 |
| 2025-11-14 | 30.18 |
| 2025-11-13 | 30.00 |
| 2025-11-12 | 29.98 |
| 2025-11-11 | 29.63 |
| 2025-11-10 | 29.08 |
| 2025-11-07 | 28.27 |
| 2025-11-06 | 28.74 |
| 2025-11-05 | 28.79 |
| 2025-11-04 | 29.11 |
| 2025-11-03 | 29.41 |
| 2025-10-31 | 29.38 |
| 2025-10-30 | 28.99 |
| 2025-10-29 | 28.80 |
| 2025-10-28 | 29.16 |
| 2025-10-27 | 29.01 |
| 2025-10-24 | 29.09 |
| 2025-10-23 | 29.18 |
| 2025-10-22 | 29.44 |
| 2025-10-21 | 29.43 |
| 2025-10-20 | 28.93 |
| 2025-10-17 | 28.78 |
| 2025-10-16 | 28.21 |
| 2025-10-15 | 28.16 |
| 2025-10-14 | 28.46 |
| 2025-10-13 | 28.12 |
| 2025-10-10 | 28.15 |